Jazz Pharmaceuticals plc enterprise value

The Enterprise Value as of November 2026 (TTM) for Jazz Pharmaceuticals plc (JAZZ) is 18.67B

According to Jazz Pharmaceuticals plc’s latest financial reports and current stock price. The company's current Enterprise Value is 18.67B. This represents a change of 12.68% compared to the average of 16.57B of the last 4 quarters.

Jazz Pharmaceuticals plc (JAZZ) Historical Enterprise Value (quarterly & annually)

How has JAZZ Enterprise Value performed in the past?

The mean historical Enterprise Value of Jazz Pharmaceuticals plc over the last ten years is 11.21B. The current 18.67B Enterprise Value has changed 66.49% with respect to the historical average. Over the past ten years (40 quarters), JAZZ's Enterprise Value was at its highest in in the September 2026 quarter at 18.59B. The Enterprise Value was at its lowest in in the March 2020 quarter at 6.65B.

Jazz Pharmaceuticals plc (JAZZ) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Jazz Pharmaceuticals plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Jazz Pharmaceuticals plc (JAZZ) Average Enterprise Value

How has JAZZ Enterprise Value performed in the past?

The current Enterprise Value of Jazz Pharmaceuticals plc (JAZZ) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Jazz Pharmaceuticals plc (JAZZ) Enterprise Value vs. Peers

How is JAZZ’s Enterprise Value compared to its peers?

Jazz Pharmaceuticals plc’s Enterprise Value is less than Genmab A/S (36.89B), less than Incyte Corporation (21.80B), greater than TG Therapeutics, Inc. (9.71B), greater than Ligand Pharmaceuticals Incorporated (7.40B), greater than MacroGenics, Inc. (68.33M), greater than Legend Biotech Corporation (3.82B), greater than Neurocrine Biosciences, Inc. (16.56B), greater than Harmony Biosciences Holdings, Inc. (1.38B), less than Shanghai Junshi Biosciences Co., Ltd. (27.52B), less than UCB S.A. (56.70B),

Build a custom stock screener for Jazz Pharmaceuticals plc (JAZZ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Jazz Pharmaceuticals plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Jazz Pharmaceuticals plc (JAZZ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Jazz Pharmaceuticals plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.